---
title: "Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293383745.md"
description: "Gilead Sciences (GILD) shares fell 2.20% to $130.28 on Tuesday, underperforming the broader market and key competitors like Johnson & Johnson and Pfizer during a positive trading session. This marks the third consecutive day of losses for Gilead, which is now trading 17.17% below its 52-week high. Trading volume reached 8.2 million, exceeding the 50-day average."
datetime: "2026-07-21T20:35:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293383745.md)
  - [en](https://longbridge.com/en/news/293383745.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293383745.md)
generator: "portal-rs"
---

# Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Gilead Sciences Inc. (GILD) slid 2.20% to $130.28 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.89% to 7,509.20 and the Dow Jones Industrial Average rising 0.74% to 52,224.64.

This was the stock's third consecutive day of losses.

Gilead Sciences Inc. closed 17.17% below its 52-week high of $157.29, which the company achieved on February 11th.

The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) rose 0.72% to $250.61, Pfizer Inc. (PFE) rose 0.77% to $24.94, and Abbott Laboratories (ABT) fell 1.96% to $99.67.

Trading volume (8.2 M) eclipsed its 50-day average volume of 7.9 M.

Data source: Dow Jones Market Data, FactSet. Data compiled July 21, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-21-26 1635ET

### Related Stocks

- [GIS.DE](https://longbridge.com/en/quote/GIS.DE.md)
- [GILD.US](https://longbridge.com/en/quote/GILD.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)

## Related News & Research

- [Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run](https://longbridge.com/en/news/297410206.md)
- [New HIV and Breast Cancer Wins Might Change The Case For Investing In Gilead Sciences (GILD)](https://longbridge.com/en/news/297483843.md)
- [Bamco Inc. NY Sells 12,000 Shares of Gilead Sciences, Inc. $GILD](https://longbridge.com/en/news/297281302.md)
- [Parallax Volatility Advisers L.P. Trims Holdings in Gilead Sciences, Inc. $GILD](https://longbridge.com/en/news/297162579.md)
- [FDA Approves Gilead's New Single Tablet HIV Regimen](https://longbridge.com/en/news/297549407.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**